345 results on '"Gokal R"'
Search Results
2. Haemodialysis
3. End-stage renal disease in Indo-Asians in the North-West of England
4. Blood glucose overestimation in diabetic patients on continuous ambulatory peritoneal dialysis for end-stage renal disease
5. Natural history and prognostic factors of diabetic nephropathy in type 2 diabetes
6. Outcomes in peritoneal dialysis and haemodialysis—a comparative assessment of survival and quality of life
7. Irish nephrological society: Proceedings of meeting held in Belfast on 15th October 1992
8. Who's for Continuous Ambulatory Peritoneal Dialysis?
9. 25. Prospective screening of patients with end-stage renal failure for asymptomatic cardiovascular disease using thallium myocardial imaging
10. Peripheral Skin Necrosis Complicating Beta-Blockage
11. Renal Papillary Necrosis After Aspirin And Alclofenac
12. Treatment Of Hyperlipidaemia In Patients On Chronic Haemodialysis
13. Minimal-Change Glomerulonephritis Associated With Circulating Anticoagulant To Factor XII
14. Continuous Ambulatory Peritoneal Dialysis: One Year's Experience In A Uk Dialysis Unit
15. Long-Term Dietary Treatment Of Hyperlipidaemia In Patients Treated With Chronic Haemodialysis
16. Familial Membranous Nephropathy
17. Peritonitis Associated With Vaginal Leakage Of Dialysis Fluid In Continuous Ambulatory Peritoneal Dialysis
18. Cephaloridine Encephalopathy
19. Functional Iron Deficiency During Erythropoietin Treatment
20. Drug Innovation, Cost‐effectiveness and Management: The Case of Erythropoietin
21. The pharmacokinetics of single doses of metoclopramide in renal failure
22. European best practice guidelines for peritoneal dialysis. 2 The initiation of dialysis
23. European best practice guidelines for peritoneal dialysis. 9 PD and transplantation
24. European best practice guidelines for peritoneal dialysis. 1 General guidelines
25. European best practice guidelines for peritoneal dialysis. 4 Continuous ambulatory peritoneal dialysis delivery systems
26. European best practice guidelines for peritoneal dialysis. 3 Peritoneal access
27. European best practice guidelines for peritoneal dialysis. 5 Peritoneal dialysis solutions
28. A randomized controlled trial of a bicarbonate - and a bicarbonate/lactate - containing dialysis solution in CAPD
29. Self-Regulating Public Servant, Profitable Internet Innovator, or Rapacious Monopoly: Assessing Google, Thinking about the Possibility of Regulation.
30. Treatment of Infections in Peritoneal Dialysis.
31. Peritoneal Dialysis as the First-Choice Treatment.
32. Peritoneal Dialysis: Prevention and Control of Infection.
33. Outcome of pregnancy following renal transplantation.
34. A controlled trial of two bicarbonate-containing dialysis fluids for CAPD - Final report.
35. Influence of Azathioprine on the Ferrokinetics of Patients with Renal Failure before and after Treatment with Erythropoietin.
36. Effects of azathioprine on response of renal anaemia to subcutaneous recombinant human erythropoietin.
37. Successful pregnancy in acute monocytic leukaemia.
38. Alternative Osmotic Agents.
39. Bone biopsy--beyond light microscopy and histodynamics.
40. Dialysis fluid cytotoxicity and inhibition of host defence in cultured human mesothelial cells are neutralized rapidly with incubation in the peritoneum.
41. Limitations of the peritoneal equilibration test in prescribing and monitoring dialysis therapy.
42. Comparative mortality from cardiovascular disease in patients with chrome renal failure.
43. Monitoring of iron requirements in renal patients on erythropoietin.
44. Influence of blood volume on the blood pressure of predialysis and peritoneal dialysis patients treated with erythropoietin.
45. Single daily overnight (12-h dwell) use of 7.5% glucose polymer (Mw 18700; Mn 7300) +0.35% glucose solution: a 3-month study.
46. Value of thallium myocardial imaging in the prediction of future cardiovascular events in patients with end-stage renal failure.
47. Serum lipoprotein (a) concentrations in patients undergoing continuous ambulatory peritoneal dialysis.
48. Low-calcium dialysis fluid and oral calcium carbonate in CAPD.A method of controlling hyperphosphataemia whilst minimizing aluminium exposure and hypercalcaemia.
49. Kinetic and Clinical Studies of β2Microglobulin in Continuous Ambulatory Peritoneal Dialysis: Influence of Renal and Enhanced Peritoneal Clearances Using Glucose Polymer.
50. Multi-Centre Study on Outcome of Treatment in Patients on Continuous Ambulatory Peritoneal Dialysis and Haemodialysis.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.